Investigation of the clinical safety and efficacy of iguratimod in patients with rheumatoid arthritis
Not Applicable
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-jRCT1080222005
- Lead Sponsor
- Eisai Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
Patients with rheumatoid arthritis
All patients who take iguratimod
Exclusion Criteria
Pregnant women or women suspected of being pregnant
Patients with a serious liver disorder
Patients with peptic ulcer
Patients with known hypersensitivity to iguratimod or any of its excipients
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy<br>DAS28
- Secondary Outcome Measures
Name Time Method